These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 10843168

  • 21. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 22. Intersubject responsiveness of high-affinity growth hormone (GH)-binding protein (GHBP) to long-term GH replacement therapy.
    De Vries WR, Koppeschaar HP, Bol E, Roelen CA, Donker GH, Doerga ME, Osman-Dualeh M, Snel YE.
    J Endocrinol Invest; 2000 Jan; 23(7):449-56. PubMed ID: 11005269
    [Abstract] [Full Text] [Related]

  • 23. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.
    Rodríguez-Arnao J, Jabbar A, Fulcher K, Besser GM, Ross RJ.
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):53-60. PubMed ID: 10468965
    [Abstract] [Full Text] [Related]

  • 24. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
    Juul A, Andersson AM, Pedersen SA, Jørgensen JO, Christiansen JS, Groome NP, Skakkebaek NE.
    Horm Res; 1998 Jul; 49(6):269-78. PubMed ID: 9623518
    [Abstract] [Full Text] [Related]

  • 25. Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
    Fisker S, Vahl N, Hansen TB, Jørgensen JO, Hagen C, Orskov H, Christiansen JS.
    Metabolism; 1997 Jul; 46(7):812-7. PubMed ID: 9225837
    [Abstract] [Full Text] [Related]

  • 26. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB, Gram J, Jensen PB, Kristiansen JH, Ekelund B, Christiansen JS, Pedersen FB.
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [Abstract] [Full Text] [Related]

  • 27. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.
    Attanasio AF, Shavrikova E, Blum WF, Cromer M, Child CJ, Paskova M, Lebl J, Chipman JJ, Shalet SM, Hypopituitary Developmental Outcome Study Group.
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4857-62. PubMed ID: 15472176
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study.
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2006 Apr; 16(2):132-42. PubMed ID: 16702006
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH, Naeraa RW, Brixen K, Kastrup KW, Mosekilde L, Jørgensen JO, Christiansen JS.
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [Abstract] [Full Text] [Related]

  • 37. Adult GH deficiency in Japanese patients: effects of GH treatment in a randomised, placebo-controlled trial.
    Chihara K, Koledova E, Shimatsu A, Kato Y, Kohno H, Tanaka T, Teramoto A, Bates PC, Attanasio AF.
    Eur J Endocrinol; 2004 Sep; 151(3):343-50. PubMed ID: 15362963
    [Abstract] [Full Text] [Related]

  • 38. Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement.
    Skjaerbaek C, Vahl N, Frystyk J, Hansen TB, Jørgensen JO, Hagen C, Christiansen JS, Orskov H.
    Eur J Endocrinol; 1997 Aug; 137(2):132-7. PubMed ID: 9272100
    [Abstract] [Full Text] [Related]

  • 39. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.
    Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Lee H, Grinspoon S.
    JAMA; 2008 Aug 06; 300(5):509-19. PubMed ID: 18677023
    [Abstract] [Full Text] [Related]

  • 40. Leptin concentrations in GH deficiency: the effect of GH insensitivity.
    Marzullo P, Buckway C, Pratt KL, Colao A, Guevara-Aguirre J, Rosenfeld RG.
    J Clin Endocrinol Metab; 2002 Feb 06; 87(2):540-5. PubMed ID: 11836282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.